Annual Report 2020

NOTESTOTHE CONSOLIDATED FINANCIAL STATEMENTS For the year ended 31 December 2020 111 The United Laboratories International Holdings Limited Annual Report 2020 24. TRADE AND BILLS RECEIVABLES, OTHER RECEIVABLES, DEPOSITS AND PREPAYMENTS (Continued) The following is an analysis of trade receivables by age, net of allowance for credit losses, presented based on dates of goods receipt, which is the same as revenue recognition date, and an analysis of bills receivables by age, net of allowance for credit losses, presented based on the bills issuance date, at the end of the reporting period: 2020 2019 RMB’000 RMB’000 Trade receivables 0 to 30 days 806,012 697,533 31 to 60 days 411,407 306,184 61 to 90 days 149,574 127,859 91 to 120 days 21,955 67,030 121 to 180 days 11,805 19,763 1,400,753 1,218,369 Bills receivables 0 to 30 days 358,164 345,572 31 to 60 days 287,311 188,439 61 to 90 days 204,825 216,072 91 to 120 days 149,526 209,528 121 to 180 days 325,678 363,268 Over 180 days 17,861 32,105 1,343,365 1,354,984 At 31 December 2020, total bills received amounting to RMB1,343,365,000 (2019: RMB1,354,984,000) and certain bills were further discounted or endorsed by the Group with full recourse. The Group continues to recognise their full carrying amounts at the end of the reporting period and details are disclosed below. All bills received by the Group are with a maturity period of less than one year. At 31 December 2020, included in the Group’s trade receivables balance are debtors with aggregate carrying amount of RMB183,334,000 (2019: RMB214,652,000) which are past due at the reporting date. Out of the past due balances, nil (2019: nil) has been past due 90 days or more. The Group does not hold any collateral over these balances. Details of impairment assessment of trade receivables, commercial bills receivables and other receivables are set out in Note 39.